MedTrace Logo

Custom Needle Preparation for Suprachoroidal Steroid Injection (One Year Results)

NCT05496530 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2022-08-11

No results posted yet for this study

Summary

Suprachoroidal drug delivery is a recent route for managing various ocular conditions. Safety and long term results are still under investigations.

Conditions

Interventions

DRUG

Suprachoroidal triamcinolone acetonide injection

Pars plana suprachoroidal injection of 4mg//0.1ml triamcinolone acetonide.

Sponsors & Collaborators

  • Benha University

    lead OTHER

Principal Investigators

  • Ahmed A Tabl · Benha University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
30 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-07-10
Primary Completion
2023-07-30
Completion
2023-08-15

Countries

  • Egypt

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05496530 on ClinicalTrials.gov